Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The 1918 influenza pandemic caused more than 20 million deaths worldwide. Thus, the potential impact of a re-emergent 1918 or 1918-like influenza virus, whether through natural means or as a result of bioterrorism, is of significant concern. The genetic determinants of the virulence of the 1918 virus have not been defined yet, nor have specific clinical prophylaxis and/or treatment interventions that would be effective against a re-emergent 1918 or 1918-like virus been identified. Based on the reported nucleotide sequences, we have reconstructed the hemagglutinin (HA), neuraminidase (NA), and matrix (M) genes of the 1918 virus. Under biosafety level 3 (agricultural) conditions, we have generated recombinant influenza viruses bearing the 1918 HA, NA, or M segments. Strikingly, recombinant viruses possessing both the 1918 HA and 1918 NA were virulent in mice. In contrast, a control virus with the HA and NA from a more recent human isolate was unable to kill mice at any dose tested. The recombinant viruses were also tested for their sensitivity to U.S. Food and Drug Administration-approved antiinfluenza virus drugs in vitro and in vivo . Recombinant viruses possessing the 1918 NA or both the 1918 HA and 1918 NA were inhibited effectively in both tissue culture and mice by the NA inhibitors, zanamivir and oseltamivir. A recombinant virus possessing the 1918 M segment was inhibited effectively both in tissue culture and in vivo by the M2 ion-channel inhibitors amantadine and rimantadine. These data suggest that current antiviral strategies would be effective in curbing the dangers of a re-emergent 1918 or 1918-like virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus
Taubenberger, J. K., Reid, A. H., Krafft, A. E., Bijwaard, K. E., & Fanning, T. G. (1997) · Science · doi:10.1126/science.275.5307.1793 · Cited by 715
Self-citationOrigin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene
Reid, A. H., Fanning, T. G., Hultin, J. V., & Taubenberger, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1651 · Cited by 607
Self-citationHayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550
America's Forgotten Pandemic: The Influenza of 1918
Crosby, A. W. (2003) · doi:10.1017/cbo9780511586576 · Cited by 357
Zanamivir in the Prevention of Influenza Among Healthy Adults: A Randomized Controlled Trial
Monto, A. S., Robinson, D. P., Herlocher, M. L., Hinson, Jr., Elliott, M. J., & Crisp, A. (1999) · JAMA · doi:10.1001/jama.282.1.31 · Cited by 321
Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
Meindl, P., Bodo, G., Palese, P., Schulman, J., & Tuppy, H. (1974) · Virology · doi:10.1016/0042-6822(74)90080-4 · Cited by 287
Self-citation
Cited by
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Neumann, G., Noda, T., & Kawaoka, Y. (2009) · Nature · doi:10.1038/nature08157 · Cited by 1,561
Characterization of the reconstructed 1918 Spanish influenza pandemic virus
Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solórzano, A., Swayne, D. E., Cox, N. J., Katz, J. M., Taubenberger, J. K., Palese, P., et al. (2005) · Science · doi:10.1126/science.1119392 · Cited by 1,327
Self-citationNeuraminidase Inhibitors for Influenza
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,094
Characterization of the 1918 influenza virus polymerase genes
Taubenberger, J. K., Reid, A. H., Lourens, R. M., Wang, R., Jin, G., & Fanning, T. G. (2005) · Nature · doi:10.1038/nature04230 · Cited by 1,066
Self-citationAberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Antiviral agents active against influenza A viruses
De Clercq, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2175 · Cited by 668
Stevens, J., Blixt, O., Glaser, L., Taubenberger, J. K., Palese, P., Paulson, J. C., & Wilson, I. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.002 · Cited by 613
Self-citationInfluenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
Self-citationTumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Pantin-Jackwood, M. J., Schultz-Cherry, S., Solórzano, A., Van Rooijen, N., Katz, J. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14933-14944.2005 · Cited by 507
Self-citationStructure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus
Stevens, J., Corper, A. L., Basler, C. F., Taubenberger, J. K., Palese, P., & Wilson, I. A. (2004) · Science · doi:10.1126/science.1093373 · Cited by 478
Self-citationEnhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus
Kobasa, D., Takada, A., Shinya, K., Hatta, M., Halfmann, P., Theriault, S., Suzuki, H., Nishimura, H., Mitamura, K., Sugaya, N., et al. (2004) · Nature · doi:10.1038/nature02951 · Cited by 455
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 452
Self-citationOseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
Ward, P., Small, I., Smith, J., Suter, P., & Dutkowski, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki018 · Cited by 428
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus
Manicassamy, B., Manicassamy, S., Belicha-Villanueva, A., Pisanelli, G., Pulendran, B., & García-Sastre, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914994107 · Cited by 423
Self-citationGlaser, L., Stevens, J., Zamarin, D., Wilson, I. A., García-Sastre, A., Tumpey, T. M., Basler, C. F., Taubenberger, J. K., & Palese, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11533-11536.2005 · Cited by 400
Self-citationJegerlehner, A., Schmitz, N., Storni, T., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5598 · Cited by 397
Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells
Ibricevic, A., Pekosz, A., Walter, M. J., Newby, C., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 391
Animal Models for Influenza Virus Pathogenesis and Transmission
Bouvier, N. M., & Lowen, A. C. (2010) · Viruses · doi:10.3390/v20801530 · Cited by 367
Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
Xu, X., Zhu, X., Dwek, R. A., Stevens, J., & Wilson, I. A. (2008) · Journal of Virology · doi:10.1128/jvi.00959-08 · Cited by 260
Acharya, R., Carnevale, V., Fiorin, G., Levine, B. G., Polishchuk, A. L., Balannik, V., Samish, I., Lamb, R. A., Pinto, L. H., DeGrado, W. F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007071107 · Cited by 258
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Chaipan, C., Kobasa, D., Bertram, S., Glowacka, I., Steffen, I., Solomon Tsegaye, T., Takeda, M., Bugge, T. H., Kim, S., Park, Y., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02205-08 · Cited by 223
“Plasmids encoding the 1918 HA (South Carolina), NA, and M2 (Brevig Mission) proteins as well as the Zaire Ebola virus glycoproteins (ZEBOV-GP), A/WSN/33 HA, A/WSN/33 NA, vesicular stomatitis virus G protein (VSV-G), TMPRSS2, TMPRSS4, and mouse matriptase-3 have been described previously (11, 13, 19, 33, 34, 36, 38, 41…”
BackgroundVan Hoeven, N., Pappas, C., Belser, J. A., Maines, T. R., Zeng, H., García-Sastre, A., Sasisekharan, R., Katz, J. M., & Tumpey, T. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813172106 · Cited by 218
Self-citationThe 1918 influenza pandemic: 100 years of questions answered and unanswered
Taubenberger, J. K., Kash, J. C., & Morens, D. M. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5485 · Cited by 189
Self-citationDiscovery and Characterization of the 1918 Pandemic Influenza Virus in Historical Context
Taubenberger, J. K., Hultin, J. V., & Morens, D. M. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s02.1 · Cited by 181
Self-citation
Metadata
- Authors
- Tumpey, T. M., García-Sastre, A., Mikulasova, A., Taubenberger, J. K., Swayne, D. E., Palese, P., & Basler, C. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-04
- Volume
- 99
- Issue
- 21
- Pages
- 13849-13854
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027070178
- Cited by
- 127
- References
- 6
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.